1. Home
  2. PRPO vs ALBT Comparison

PRPO vs ALBT Comparison

Compare PRPO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$24.31

Market Cap

32.4M

Sector

Industrials

ML Signal

N/A

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

N/A

Current Price

$0.92

Market Cap

5.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRPO
ALBT
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRPO
ALBT
Price
$24.31
$0.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.5K
140.9K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,800,000.00
$1,611,940.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.95
N/A
52 Week Low
$3.90
$0.90
52 Week High
$28.50
$11.66

Technical Indicators

Market Signals
Indicator
PRPO
ALBT
Relative Strength Index (RSI) 54.58 27.80
Support Level $24.00 $1.37
Resistance Level $25.62 $1.77
Average True Range (ATR) 1.26 0.19
MACD -0.19 -0.03
Stochastic Oscillator 50.57 0.99

Price Performance

Historical Comparison
PRPO
ALBT

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: